Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rocuronium onset time, duration of action and intubation conditions in patients aged 80 years and above
2019-004343-76Phase 4Completed
- Sponsor
- Rigshospitalet
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of rocuronium (2 arms), sponsored by Rigshospitalet. Primary endpoint: Onset time. Started Nov 2019; status: completed.
02
Drugs
rocuronium
Beyond the preview
Go deeper on 2019-004343-76.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004343-76.